Physician profile
Brian Ashford
NPI 1265622732
$725.85
in general payments reported to CMS, 2019-2025
15 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $473 · 2020: $62.17 · 2021: $37.64 · 2022: $38.14 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $114.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $223.07 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $126.75 | 2019-2025 | Exparel |
| Amgen INC. | $89.19 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $46.67 | 2019 | |
| Mylan Pharmaceuticals INC. | $44.29 | 2019-2021 | |
| Minerva Surgical, INC | $26.63 | 2019 | |
| Therapeuticsmd, INC. | $26.48 | 2019 | |
| Ethicon US, LLC | $23.52 | 2019 | |
| Next Science LLC | $21.39 | 2019 | |
| Becton, Dickinson and Company | $19.75 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $19.15 | 2019 | |
| Roche Diagnostics Corporation | $18.33 | 2019 | |
| Mallinckrodt Enterprises LLC | $17.56 | 2019 | |
| Allergan, INC. | $11.54 | 2020 | |
| Lupin INC. | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Ashford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.